WO2001020533A3 - Creation d'une base de donnees biochimiques et procedes d'utilisation - Google Patents

Creation d'une base de donnees biochimiques et procedes d'utilisation Download PDF

Info

Publication number
WO2001020533A3
WO2001020533A3 PCT/US2000/025183 US0025183W WO0120533A3 WO 2001020533 A3 WO2001020533 A3 WO 2001020533A3 US 0025183 W US0025183 W US 0025183W WO 0120533 A3 WO0120533 A3 WO 0120533A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood
patient
biochemicals
concentrations
database
Prior art date
Application number
PCT/US2000/025183
Other languages
English (en)
Other versions
WO2001020533A2 (fr
Inventor
Mark B Chandler
Van S Chandler
Original Assignee
Luminex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luminex Corp filed Critical Luminex Corp
Priority to AU75799/00A priority Critical patent/AU7579900A/en
Priority to EP00965004A priority patent/EP1250675A2/fr
Publication of WO2001020533A2 publication Critical patent/WO2001020533A2/fr
Publication of WO2001020533A3 publication Critical patent/WO2001020533A3/fr

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention est basée sur l'observation que toutes les maladies peuvent être diagnostiquées par analyse d'au moins 200/300 substances biochimiques présentes dans le sang du patient. De plus, on peut également prédire l'évolution d'une maladie à partir du profil de ces substances biochimiques dans le sang. L'invention met en application des procédés automatisés rapides afin de déterminer les concentrations de ces substances biochimiques dans le sang et compare ces concentrations à une base de données contenant des informations obtenues à partir d'une étude prolongée sur de nombreuses années et effectuée sur environ 200 000 personnes. En se basant sur les corrélations découvertes entre les concentrations biochimiques dans le sang et l'existence d'états pathologiques, l'invention permet de diagnostiquer un état pathologique actuel chez le patient et a la capacité de prédire l'apparition de maladies futures chez ce patient.
PCT/US2000/025183 1999-09-15 2000-09-15 Creation d'une base de donnees biochimiques et procedes d'utilisation WO2001020533A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU75799/00A AU7579900A (en) 1999-09-15 2000-09-15 Creation of a database of biochemical data and methods of use
EP00965004A EP1250675A2 (fr) 1999-09-15 2000-09-15 Creation d'une base de donnees biochimiques et procedes d'utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15394199P 1999-09-15 1999-09-15
US60/153,941 1999-09-15

Publications (2)

Publication Number Publication Date
WO2001020533A2 WO2001020533A2 (fr) 2001-03-22
WO2001020533A3 true WO2001020533A3 (fr) 2002-08-15

Family

ID=22549345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/025183 WO2001020533A2 (fr) 1999-09-15 2000-09-15 Creation d'une base de donnees biochimiques et procedes d'utilisation

Country Status (3)

Country Link
EP (1) EP1250675A2 (fr)
AU (1) AU7579900A (fr)
WO (1) WO2001020533A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US9360476B2 (en) 2006-12-19 2016-06-07 Fio Corporation Microfluidic system and method to test for target molecules in a biological sample
US9459200B2 (en) 2008-08-29 2016-10-04 Fio Corporation Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952696A0 (en) * 2002-11-14 2002-11-28 Genomics Research Partners Pty Ltd Status determination
US20040236188A1 (en) * 2003-05-19 2004-11-25 Ge Medical Systems Information Method and apparatus for monitoring using a mathematical model
US7198900B2 (en) 2003-08-29 2007-04-03 Applera Corporation Multiplex detection compositions, methods, and kits
CA2559244A1 (fr) * 2004-03-11 2005-09-22 Baylor College Of Medicine Procede de prediction du risque de progression de bph
CA2702367C (fr) 2007-10-12 2012-08-21 Fio Corporation Procede de focalisation d'ecoulement et systeme de creation de volumes concentres de microbilles, et microbilles formees a la suite de celui-ci
CN102132330B (zh) 2008-06-25 2015-07-22 Fio公司 生物威胁警报系统
CN104374932A (zh) 2009-01-13 2015-02-25 Fio公司 与电子设备和快速诊断测试中的测试盒结合使用的手持诊断测试设备
WO2012125807A2 (fr) 2011-03-17 2012-09-20 Cernostics, Inc. Systèmes et compositions pour le diagnostic de l'œsophage de barrett et leurs procédés d'utilisation
CN108073787A (zh) * 2017-12-30 2018-05-25 齐鲁工业大学 一种基于肌肤本底指标而定制护肤品的方法
WO2023220201A1 (fr) 2022-05-10 2023-11-16 Google Llc Génération de résumé pour résumés en direct avec personnalisation d'utilisateur et de dispositif

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002360A1 (fr) * 1991-07-16 1993-02-04 Transmed Biotech Incorporated Procedes et compositions d'analyse simultanee d'analytes multiples
WO1997014028A2 (fr) * 1995-10-11 1997-04-17 Luminex Corporation Procedes et appareil d'analyse multiplexee de specimens cliniques
US5687716A (en) * 1995-11-15 1997-11-18 Kaufmann; Peter Selective differentiating diagnostic process based on broad data bases
WO1998035609A1 (fr) * 1997-02-14 1998-08-20 Biomar International, Inc. Systeme de prediction de l'etat futur de sante
WO1999019515A1 (fr) * 1997-10-14 1999-04-22 Luminex Corporation Particules fluorescentes de precision, et procede de fabrication et mode d'utilisation associes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002360A1 (fr) * 1991-07-16 1993-02-04 Transmed Biotech Incorporated Procedes et compositions d'analyse simultanee d'analytes multiples
WO1997014028A2 (fr) * 1995-10-11 1997-04-17 Luminex Corporation Procedes et appareil d'analyse multiplexee de specimens cliniques
US5687716A (en) * 1995-11-15 1997-11-18 Kaufmann; Peter Selective differentiating diagnostic process based on broad data bases
WO1998035609A1 (fr) * 1997-02-14 1998-08-20 Biomar International, Inc. Systeme de prediction de l'etat futur de sante
WO1999019515A1 (fr) * 1997-10-14 1999-04-22 Luminex Corporation Particules fluorescentes de precision, et procede de fabrication et mode d'utilisation associes

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US8597899B2 (en) 2006-05-17 2013-12-03 Cernostics, Inc. Method for automated tissue analysis
US9360476B2 (en) 2006-12-19 2016-06-07 Fio Corporation Microfluidic system and method to test for target molecules in a biological sample
US9459200B2 (en) 2008-08-29 2016-10-04 Fio Corporation Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples

Also Published As

Publication number Publication date
AU7579900A (en) 2001-04-17
EP1250675A2 (fr) 2002-10-23
WO2001020533A2 (fr) 2001-03-22

Similar Documents

Publication Publication Date Title
WO2001020533A3 (fr) Creation d'une base de donnees biochimiques et procedes d'utilisation
CA2263063A1 (fr) Methode pour diagnostiquer et distinguer les accidents vasculaires cerebraux et dispositifs de diagnostic utilises a cette fin
NO20050186D0 (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
WO2005023086A3 (fr) Systemes, procedes et produits de programme informatique conçus pour analyser des attributs de vaisseaux aux fins de diagnostic, de stadification de maladie, et de planification chirurgicale
WO2004020968A3 (fr) Mutations de nod2 associees a la stenose fibreuse chez des patients souffrant de la maladie de crohn
WO2001069513A3 (fr) Systeme et procede pour obtenir, traiter et evaluer des informations relatives au patient pour diagnostiquer une maladie et selectionner un traitement
Sandsmark Clinical outcomes after traumatic brain injury
EP0962878A3 (fr) Algorithme de reflexe pour diagnose tôt et économique des infarctus du myocarde apte a être utilisée dans des platformes de diagnostic automatisé
WO2001040517A3 (fr) Evaluation et prediction cliniques obtenues par analyse d"expression genique
WO1998027226B1 (fr) Procede d'etablissement d'un pronostic pour un patient atteint d'une maladie neurologique
EP1480251A3 (fr) Système d' analyse de mélanges complexes de fluides biologiques et d' autres fluides à des fins d' identification de leurs propriétés biologiques.
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
WO2006065763A3 (fr) Utilisation d'un electroencephalogramme quantitatif (qeeg) seul et/ou d'une autre technologie et/ou en combinaison avec une analyse genomique et/ou proteomique et/ou biochimique et/ou autres modalites diagnostiques
EP1418523A3 (fr) Système d'aide au diagnostic du diabète
CN105574334B (zh) 医疗信息处理方法和系统
WO2006036960A3 (fr) Systeme et procede d'evaluation clinique d'une fonction motrice
Boeker et al. Diagnosing schizophrenia from activity records using Hidden Markov model parameters
WO2001016857A3 (fr) Systeme et procede d'evaluation de maladies de plantes agricoles par voie genomique et proteomique grace a la comparaison de profils d'expression
WO2004001422A3 (fr) Utilisation, en matiere de diagnostic et de therapie de maladies neurodegeneratives, de la proteine 2 (g3bp2) se fixant au domaine sh3 de la proteine activant la ras gtpase
WO2002096266A3 (fr) Methode et systeme d'analyse optique permettant de detecter un etat pathologique
Smith et al. Implementation of intelligent decision support systems in health care
Mareeswari et al. Predicting Chronic Kidney Disease Using KNN Algorithm
Clark Modern concepts of epidemiology
Baron et al. Characteristics of readmitted psychiatric inpatients
NO992625D0 (no) Automatisert diagnostisk system for implementering av immunoanalyser og kliniske kjemiske analyser i henhold til refleksalgoritmer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000965004

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000965004

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP